Tachibana, Hidekazu
106  Ergebnisse:
Personensuche X
?
1

First-line dual immune checkpoint inhibitor therapies versu..:

Ishihara, Hiroki ; Omae, Kenji ; Nemoto, Yuki...
International Journal of Clinical Oncology.  29 (2024)  4 - p. 473-480 , 2024
 
?
 
?
 
?
 
?
6

Impact of sex on prognosis in patients with advanced renal ..:

Nemoto, Yuki ; Ishihara, Hiroki ; Nakamura, Kazutaka...
Japanese Journal of Clinical Oncology.  53 (2023)  7 - p. 611-618 , 2023
 
?
7

Predictive factors and oncological outcomes of pathological..:

Ishiyama, Ryo ; Omae, Kenji ; Kondo, Tsunenori...
Japanese Journal of Clinical Oncology.  54 (2023)  2 - p. 160-166 , 2023
 
?
8

Association between lung immune prognostic index and surviv..:

Nakamura, Kazutaka ; Ishiyama, Yudai ; Nemoto, Yuki...
International Journal of Clinical Oncology.  28 (2023)  7 - p. 913-921 , 2023
 
?
9

Real-world efficacy and safety of cabozantinib following im..:

Ishihara, Hiroki ; Nemoto, Yuki ; Tachibana, Hidekazu...
Japanese Journal of Clinical Oncology.  53 (2023)  10 - p. 977-983 , 2023
 
?
10

Higher risk of intraoperative bleeding in right‐sided renal..:

Tachibana, Hidekazu ; Kobari, Yuki ; Fukuda, Hironori...
Asian Journal of Endoscopic Surgery.  16 (2023)  3 - p. 432-440 , 2023
 
?
 
?
12

Surgical outcomes for older patients with renal cell carcin..:

Ishiyama, Yudai ; Kondo, Tsunenori ; Tachibana, Hidekazu...
Urologic Oncology: Seminars and Original Investigations.  40 (2022)  3 - p. 110.e11-110.e18 , 2022
 
?
 
1-15